Summary
The distribution of the Burkitt's lymphoma-associated antigen (BLA) or globotriaosylceramide (Pk antigen) in normal human tissues and in 194 haematopoietic neoplasms was demonstrated by immunoperoxidase labelling of frozen tissue sections with monoclonal antibody 38.13. Staining was seen in most tissues of the body and was most pronounced in the epithelial compartments. In normal lymphoid tissue only dendritic reticulum cells, sinus-lining cells, macrophages and endothelial cells stained whereas lymphocytes were unlabelled. Among neoplasms, BLA was expressed strongly in 4/5 Burkitt's lymphomas. Rather weak expression was seen in 8/120 of the other B-cell lymphomas which included cases of pre-B-stage mid-stage and secretory-stage B-cell maturation. Expression of BLA was also found in 3/54 T-cell lymphomas (all 3 of activated T-cell phenotype), 1 case of Hodgkin's disease and in 1 case of monocytic sarcoma. We found no correlation between the expression of BLA and any particular surface Ig-type in the B-cell lymphomas. We conclude that BLA is neither a tumour-specific antigen, nor a typical B-cell differentiation antigen. The results concerned with the antigen distribution in human tissues and haematopoietic neoplasms preclude the use of 38.13 as a reagent for diagnosis or specific in vivo immunotherapy of Burkitt's lymphoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ehlin-Henriksson B, Klein G (1984) Distinction between Burkitt lymphoma subgroups by monoclonal antibodies: relationships between antigen expression and type of chromosomal translocation. Int J Cancer 33:459–463
Gordon J, Mellstedt H, Åman P, Biberfield, P, Björkholm M, Klein G (1983) Phenotypes in chronic B-lymphocytic leukemia probed by monoclonal antibodies and immunoglobulin secretion studies: Identification of stages of maturation arrest and the relation to clinical findings. Blood 62:910–917
Klein G, Manneborg-Sandlund A, Ehlin-Henriksson B, Godal T, Wiels J, Tursz T (1983) Expression of the BLA antigen, defined by the monoclonal 38.13 antibody, on Burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other B-cell lymphomas and leukemias. Int J Cancer 31:535–542
Lipinski M, Nudelman ED, Wiels J, Parsons M (1982) Monoclonal antibody defining a Burkitt's lymphoma-associated antigen detects carbohydrate on neutral glocolipid. J Immunol 129:2301–2304
Murray LJ, Habeshaw JA, Wiels J, Greaves MF (1985) Expression of Burkitt lymphoma-associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal-centre B cells. Int J Cancer 36:561–565
Nudelman E, Kannagi R, Hakomori S, Parsons M, Lipinski M, Wiels J, Fellous M, Tursz T (1983) A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody Science 220:509–511
Pallesen G, Knudsen LM (1985) Leucocyte antigens in human post mortem tissues: their preservation and loss as demonstrated by monoclonal antibody immunohistological staining. Histopathology 9:791–804
Pallesen G, Beverley PCL, Lane EB, Madsen M, Mason DY, Stein H (1984) Nature of non-B, non-T lymphomas: an immunohistological study on frozen tissues using monoclonal antibodies. J Clin Pathol 37:911–918
Rowe M, Rooney CM, Rickinson AB, Lenoir GM, Rupani H, Moss DJ, Stein H, Epstein MA (1985) Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma. Int J Cancer 35:435–441
Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K (1985) The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue. Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848–858
Wiels J, Fellous M, Tursz T (1981) Monoclonal antibody against a Burkitt lymphoma-associated antigen. Proc Natl Acad Sci USA 78:6485–6488
Wiels J, Lenoir GM, Fellous M, Lipinski M, Salomon JC, Tetaud C, Tursz T (1982) A monoclonal antibody with anti-Burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines. Int J Cancer 29:653–658
Wiels J, Junqua S, Dujardin P, Le Pecq J-B, Tursz T (1984) Properties of immunotoxins agains a glycolipid antigen associated with Burkitt's lymphoma. Cancer Res 44:129–133
Wils P, Junqua S, Le Pecq J-B (1986) Determination of antibody-complement mediated cytotoxicity using ATP release induced by a monoclonal antibody against the Burkitt lymphoma associated globotriaosylceramide antigen. J Immunol Methods 87:217–222
Author information
Authors and Affiliations
Additional information
Supported by the Danish Medical Research Council and the Danish Cancer Society
Rights and permissions
About this article
Cite this article
Pallesen, G., Zeuthen, J. Distribution of the Burkitt's lymphoma-associated antigen (BLA) in normal human tissue and malignant lymphoma as defined by immunohistological staining with monoclonal antibody 38.13. J Cancer Res Clin Oncol 113, 78–86 (1987). https://doi.org/10.1007/BF00389971
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00389971